The use of photodynamic therapy (PDT) as a new approach to treat localized Candida infections is an emerging and promising field. The aim of this study was to verify the photodynamic efficacy against Candida albicans biofilms of two new benzo[a]phenoxazinium photosensitizers, N-[5-(3-hydroxypropylamino)-10-methyl-9H-benzo[a]phenoxazin-9-ylidene]ethanaminium chloride (FSc) and N-(5-(11-hydroxyundecylamino)-10-methyl-9H-benzo[a]phenoxazin-9-ylidene)ethanaminium chloride (FSd)
This study evaluated the photodynamic inactivation (PDI) mediated by Photodithazine® (PDZ) against 1...
Photodynamic antimicrobial therapy Background: Photodynamic antimicrobial therapy is proposed as a p...
Fungal infections are increasing in prevalence worldwide, especially in immunocompromised individual...
The use of photodynamic therapy (PDT) as a new approach to treat localized Candida infections is an ...
The use of Antimicrobial Photodynamic Therapy (APDT) as a new approach to treat localized Candida in...
Antimicrobial photodynamic therapy (aPDT) is a medical treatment based on the use of a light source ...
Candida albicans is the most commonly encountered human fungal pathogen, and it is traditionally tre...
Candida albicans is an opportunistic pathogen that often causes skin infections such as oral thrush,...
Objectives: Photodynamic therapy (PDT) utilizes light to activate a photosensitizing agent (photose...
P>Although photodynamic therapy (PDT) has shown great promise for the inactivation of Candida specie...
Background/aim: This study was designed to evaluate the effect of antimicrobial photodynamic treatme...
Photodynamic inactivation (PDI) has been shown to be a potential treatment modality against Candida ...
The formation of biofilms by Candida and the increasing resistance of Candida species to antifungals...
Background: A large number of systemic diseases can be linked to oral candida pathogenicity. The glo...
Candida albicans is an opportunistic fungal pathogen that causes both superficial and systemic infec...
This study evaluated the photodynamic inactivation (PDI) mediated by Photodithazine® (PDZ) against 1...
Photodynamic antimicrobial therapy Background: Photodynamic antimicrobial therapy is proposed as a p...
Fungal infections are increasing in prevalence worldwide, especially in immunocompromised individual...
The use of photodynamic therapy (PDT) as a new approach to treat localized Candida infections is an ...
The use of Antimicrobial Photodynamic Therapy (APDT) as a new approach to treat localized Candida in...
Antimicrobial photodynamic therapy (aPDT) is a medical treatment based on the use of a light source ...
Candida albicans is the most commonly encountered human fungal pathogen, and it is traditionally tre...
Candida albicans is an opportunistic pathogen that often causes skin infections such as oral thrush,...
Objectives: Photodynamic therapy (PDT) utilizes light to activate a photosensitizing agent (photose...
P>Although photodynamic therapy (PDT) has shown great promise for the inactivation of Candida specie...
Background/aim: This study was designed to evaluate the effect of antimicrobial photodynamic treatme...
Photodynamic inactivation (PDI) has been shown to be a potential treatment modality against Candida ...
The formation of biofilms by Candida and the increasing resistance of Candida species to antifungals...
Background: A large number of systemic diseases can be linked to oral candida pathogenicity. The glo...
Candida albicans is an opportunistic fungal pathogen that causes both superficial and systemic infec...
This study evaluated the photodynamic inactivation (PDI) mediated by Photodithazine® (PDZ) against 1...
Photodynamic antimicrobial therapy Background: Photodynamic antimicrobial therapy is proposed as a p...
Fungal infections are increasing in prevalence worldwide, especially in immunocompromised individual...